| |
|
| |
 |
| |
| Leadership Team |
| |
| |
|
|
|
 |
 |
 |
 |
| |
|
|
|
Agnes Schiewe, PhD
Director GCO
| Close |
|
|
Agnes Schiewe, PhD
Director GCO
Dr Schiewe has been with Ecron Acunova since 1993. Having joined as a Clinical Research Associate, her exemplary performance quickly involved her with project management functions in 1995, after which she rose to being Director Clinical Research from 1999 onwards. She has been critical in expanding the Ecron Acunova partner network all over the world and has been designated as Ecron Acunova’s Director Global Clinical Operations in 2010. Dr Schiewe's managerial and team leading skills predestine her for the supervision of project performance, cost control and manpower management. Dr Schiewe has supervised about 50 multi-national clinical trials (phase II - phase IV) in Western and Eastern Europe as well as in South America. Some key areas include oncology, cardiovascular diseases, gastrointestinal diseases and hormone replacement therapy.
She had been working as an Assistant Lecturer at the chair of phytopathology of the University of Constance before she joined Ecron Acunova. Dr Schiewe is a member of the German Society for Pharmaceutical Medicine (DGPharMed). She is an MSc in Biology and was awarded a PhD by the Faculty of Biology of the University of Constance (Germany). |
|
|
|
Ayaaz Hussain Khan, PhD
Sr VP – BA/BE
| Close |
|
|
Ayaaz Hussain Khan, PhD
Sr VP – BA/BE
As the Senior Vice President – BA/BE Services, based in Manipal Dr Khan brings with him an experience of conducting over 250 BA/BE studies and has been part of various regulatory audits like USFDA, ANVISA, AFSSAPS-France and DCGI India.
He started his career with Ranbaxy Research Laboratories where he was responsible for method development and validation of drugs and / or metabolites for BA/BE studies using LCMSMS. He was sponsored by Ranbaxy Labs for a Senior Research Fellowship for Doctoral Research at Hamdard University. After his stint with Ranbaxy, he was in-charge of the pharmacokinetic unit at Orchid Healthcare, Chennai responsible for biostudies with the clinical team with the credit of conducting over 22 studies in the in-house centre.
Dr Khan moved to GVK Biosciences, Hyderabad as Principal Scientist. As a Project Director, he was responsible for the conduct of BA/BE studies and has managed the facility of 4 clinics with 144 beds and the bioanalytical facility.
Dr Khan has completed PhD in Pharmaceutical Medicine with specialization in Clinical Pharmacokinetics from Jamia Hamdard University, New Delhi. He completed M.Pharm from BIT, Ranchi and is a gold medalist in pharmacy from his graduating University from The Tamil Nadu Dr. MGR Medical University, Chennai. Dr Khan is a member of Indian Pharmacological Society. |
|
|
|
Bernd Wagner, PhD
Dir QA & Regulatory
| Close |
|
|
Bernd Wagner, PhD
Dir QA & Regulatory
Bernd is with Ecron Acunova since 2009 and has extensive experience of Quality Assurance (GCP), Quality Management (ISO 9000 ff) and International Project/Program Management in drug development (phase II – Marketing Authorization).
Prior to his current role, Bernd has served in several senior manager positions for Pharmaceutical, CRO and Medical Device Companies since starting his professional career as a CRA in 1991.
During his function as Project Leader, Bernd successfully led drug development projects to accomplish European registration.
As an ISO 9000 certified QA Manager, his expertise and proven leadership has been instrumental in setting up and maintaining Quality Assurance systems including analysis and improvement of business processes and validation of computerized systems.
In addition to his varied skills and experience Bernd holds a PhD in Biology. |
| |
|
|
Ernst Bluemner,
MD & MSc
Director Biometrics,
Europe
| Close |
|
|
Ernst Bluemner, MD & MSc
Director Biometrics, Europe
Dr Bluemner has been with Ecron Acunova since 2001. With over 25 years enriched experience in Clinical Research, he is responsible for various aspects in the project progress namely planning, data management, statistics and medical writing. Dr Bluemner has provided biometrical guidance for numerous multi-national clinical trials (phase II - phase IV) in Western and Eastern Europe as well as in South America. The key areas include oncology, cardiovascular diseases, gastrointestinal diseases, skin diseases, and hormone replacement therapy.
Prior to Ecron Acunova, he had been with Max Planck Institute for Plasma Physics as Data analyst and programmer in Garching (Germany) and as Director Biometrics at Staticon International in Martinsried (Germany). Dr Bluemner is a member of the German Society for Medical Informatics, Biometrics and Epidemiology (GMDS) and the International Biometric Society. He is also a member of the Drug Information Association (DIA). In 1993 he was awarded with the E.W. Baader prize in Industrial Medicine.
Dr Bluemner is an MSc in Mathematics and was awarded an MD by the Ludwig Maximilian University in Munich (Germany). |
|
|
|
| |
|
|
|
 |
 |
 |
 |
| |
|
|
|
Liong Hui Cien Linda,
Director Operations, South East Asia
| Close |
|
|
Liong Hui Cien Linda
Director Operations, South East Asia
Liong Hui Cien Linda as Director Operations, South East Asia is with Ecron Acunova since 2012. In this role Linda will be responsible for expansion of Ecron Acunova into the new geographies in South East Asia. She will also be responsible for the delivery of all the clinical trial related operations. She will also mentor and guide the clinical operations team within SE Asia.
Prior to joining us, Linda was working with Singapore Clinical Research Institute Pte. Ltd. as Head of Strategic Operations and Quality Assurance. She was responsible for clinical research networks, Clinical Operations Efficiency Research, Contract Management and Financial Management and Continuous process improvements, etc. Linda worked in various capacities in Novartis and Eli Lilly group companies in the past and was also responsible for establishing the Novartis Philippines Clinical Operations. During her early stint of experience she had worked as Pharmacist at three different hospitals.
Linda has over 18 years of experience with healthcare and clinical research industry. She has extensive functional experience in clinical operations & data management, strategic business, quality assurance and training.
Linda has completed Bachelor of Science (Pharmacy) from National University of Singapore and MSc in Clinical Pharmacy from Queen’s University of Belfast. She also has an MBA from University of Western Australia, Perth. |
|
|
|
Christian Drummer,
Adj. Prof., MD
Global Medical Director
| Close |
|
|
Christian Drummer, Adj. Prof., MD
Global Medical Director
Adj. Prof., Dr Drummer joined Ecron Acunova in 2008 as a Medical Manager. He has over 20 years of professional experience. He has continuously expanded medical and safety services. Currently he is Head of Medical Services and Pharmacovigilance. Since 2011, he is Global Medical Director.
Adj. Prof., Dr Drummer is certified specialist in clinical pharmacology. He participated in over 70 clinical studies phase I to IV, many of them as project manager and medical expert (LKP). He is member of various scientific societies like American Society of Hypertension, American Physiological Society, German Society of Pharmacology and Toxicology, German Society of Physiology, PV working group of German Society for Good Research Practice.
He held different positions at the Klinikum Innenstadt of University of Munich, the Institute of Aerospace Medicine and at CobraMed before he joined Ecron Acunova. He was awarded MD by the University of Munich (Germany) and a habilitation in clinical pharmacology at the University of Aachen (Germany). |
|
|
|
Sabine Kuehnau, PhD
Director Marketing & Contracts
| Close |
|
|
Sabine Kuehnau, PhD
Director Marketing & Contracts
Dr Kuehnau has been with Ecron Acunova since 1992, actively involved in the Company development from a national to an international full-service CRO. She was responsible for project management and proposal management as per client needs in the pharmaceutical, biotech and device industry. Subsequently she was responsible for the supervision of project performances, cost control, proposals, personnel affairs and day-to-day business. Dr. Kuehnau has managed more than 100 national and multi-national clinical projects (mainly phase II - phase IV), performed mainly in Western and Eastern Europe. The key areas include rheumatology, gastroenterology, gynecology, pulmonology, dermatology, cardiovascular diseases etc.
Prior to ECRON, Dr Kuehnau began her career in 1991 as a medical writer. In addition, she has been the Production Manager according to AMG (German Drug Act) in 2006 and 2007.
Dr Kuehnau is a member of the German Society for Pharmaceutical Medicine (DGPharMed). She is an MSc in Biology and was awarded a PhD by the Faculty of Biology of the University of Constance (Germany). |
|
|
|
Anand Bidarkar, BDS
VP – Business Development
| Close |
|
|
Anand Bidarkar, BDS
VP – Business Development
Dr. Anand Bidarkar as Vice President – Business Development is responsible for the Business Development and proposal development function for Asia, UK and US geographies. He is accountable for orders, sales, marketing programs, channel partner development in Asia, UK and US. Anand works closely with the BD & Proposal teams in Frankfurt and Copenhagen for global bids.
Prior to joining us, Anand was working with SIRO Clinpharm as Vice President, Strategic Business Development responsible for Americas, Asia Pac & UK. He was part of the senior management core team that transformed the company in 3 years from a single country, part service provider to a multinational, full service clinical research and clinical IT outsourcing firm . He spearheaded alliance formation with complimentary service providers and transformed the business model of the company from being dependent on single project - single country contracts to program level, multinational deals. In his six years stint with Siro, he has held various positions from Senior Business Manager to Vice President – Service Delivery with inVentiv Siro.
Anand has over 12 years of experience with healthcare and life sciences industry. He has extensive functional experience in operations, business development, strategic partnerships and leading business units with multibillion dollar groups like Novartis, inVentiv and Apollo Hospitals as well as with mid sized firms like Sun Pharmaceuticals.
Anand has completed Bachelor of Dental Surgery, Dentistry from AMEs Dental College and Hospital. He is an Masters in Business Administration from S.P. Jain Institute of Management & Research. He has attended Executive development programs of IIM, Ahmadabad and Harvard Business School. |
|
|
|
| |
|
|
|
|
|
|
|
